Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 11-20 of 20 (Search time: 0.011 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2017Effects of age, gender and statin dose on lipid levels: results from the VOYAGER meta-analysis databaseKarlson, B.; Palmer, M.; Nicholls, S.; Barter, P.; Lundman, P.
2015To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in each of the four statin benefit groups identified by the 2013 American College of Cardiology/American Heart Association guidelines? A VOYAGER meta-analysisKarlson, B.; Palmer, M.; Nicholls, S.; Lundman, P.; Barter, P.
2017Aldosterone does not predict cardiovascular events following acute coronary syndrome in patients initially without heart failurePitts, R.; Gunzburger, E.; Ballantyne, C.; Barter, P.; Kallend, D.; Leiter, L.; Leitersdorf, E.; Nicholls, S.; Shah, P.; Tardif, J.; Olsson, A.; McMurray, J.; Kittelson, J.; Schwartz, G.
2013Achievement of 2011 European low-density lipoprotein cholesterol (LDL-C) goals of either <70 mg/dl or ≥50% reduction in high-risk patients: results from VOYAGERKarlson, B.; Nicholls, S.; Lundman, P.; Palmer, M.; Barter, P.
2018Association of lipoprotein(a) with risk of recurrent ischemic events following acute coronary syndrome: analysis of the dal-outcomes randomized clinical trialSchwartz, G.; Ballantyne, C.; Barter, P.; Kallend, D.; Leiter, L.; Leitersdorf, E.; McMurray, J.; Nicholls, S.; Olsson, A.; Shah, P.; Tardif, J.-.C.; Kittelson, J.
2014Achievement of combined goals of low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol with three different statins: results from VOYAGERKarlson, B.; Toth, P.; Palmer, M.; Barter, P.; Nicholls, S.
2015Clinical guidelines on hyperlipidaemia: recent developments, future challenges and the need for an Australian reviewSullivan, D.; Watts, G.; Nicholls, S.; Barter, P.; Grenfell, R.; Chow, C.; Tonkin, A.; Keech, A.
2015Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: rationale and design of the ACCELERATE trialNicholls, S.; Lincoff, A.; Barter, P.; Brewer, H.; Fox, K.; Gibson, C.; Grainger, C.; Menon, V.; Montalescot, G.; Rader, D.; Tall, A.; McErlean, E.; Riesmeyer, J.; Vangerow, B.; Ruotolo, G.; Weerakkody, G.; Nissen, S.
2019Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: a VOYAGER analysisPalmer, M.; Barter, P.; Lundman, P.; Nicholls, S.; Toth, P.; Karlson, B.
2014High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: Insights from SATURNStegman, B.; Puri, R.; Cho, L.; Shao, M.; Ballantyne, C.; Barter, P.; Chapman, M.; Erbel, R.; Libby, P.; Raichlen, J.; Uno, K.; Kataoka, Y.; Nissen, S.; Nicholls, S.